Medical Resource Use and Cost of Venlafaxine or Tricyclic Antidepressant Therapy: Following Selective Serotonin Reuptake Inhibitor Therapy for Depression

By Griffiths R.I.  

PharmacoEconomics, Vol. 15, Iss. 5, 1999-05 ,pp. : 495-505

Adis International

Access to resources Recommend Favorite

Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence

By Zinner Norman R  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1559-1566

Informa Healthcare

Access to resources Recommend Favorite

A randomised, double‐blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine†

By  

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 4, 2015-07 ,pp. : 327-327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Studies of four novel diphenylbutylpiperazinepyridyl derivatives on release and inhibition of reuptake of dopamine, serotonin and noradrenaline by rat brain in vitro

By Pettersson E.  

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 131-135

Elsevier

Access to resources Recommend Favorite

Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine

By Hajos-Korcsok  

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 101-107

Elsevier

Access to resources Recommend Favorite